Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Alba M et al. – Across sitagliptin doses in this study, the similarity of the 24–h WMG concentrations and the similarity of the corrected DPP–4 inhibition values support prior findings that the maximal glucose–lowering efficacy of sitagliptin is achieved with once–daily dosing of 100mg.

Related Articles

FDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09    Relevance Score: 87%

Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation
Journal of Diabetes and its Complications, 10/29/09    Relevance Score: 85%

Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone
Diabetes, Obesity and Metabolism, 10/06/09    Relevance Score: 82%

Today in Diabetes...keeping you current

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/09/09

Impaired fasting glucose as a treatment target in diabetes management
Current Cardiology Reports, 12/09/09

Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS)
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address